Takeda Pharmaceutical TAK
NYSE TAK
$18.13 -0.22 (-1.17%)
As of: Aug 20, 2026 · 3:59 PM EDT

Takeda Pharmaceutical (TAK) Cash from Investing Activities Growth (1y) (2019 - 2026)

Takeda Pharmaceutical (TAK) Cash from Investing Activities Growth (1y) (2019 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Growth (1y) (Qtr)
1 Haleon 43.83 Bn 42.86 Bn - -
2 Teva Pharmaceutical Industries 42.87 Bn 39.22 Bn 2.15 Bn -308.05%
3 Zoetis 31.41 Bn 29.73 Bn 1.05 Bn -41.51%
4 Takeda Pharmaceutical 28.55 Bn 22.75 Bn 5.10 Bn -139.86%
5 United Therapeutics 22.08 Bn 19.42 Bn 683.80 Mn 129.18%
6 Viatris 18.73 Bn 17.84 Bn 1.46 Bn 1.71%
7 Neurocrine Biosciences 15.44 Bn 15.05 Bn 935.80 Mn -366.90%
8 Elanco Animal Health 11.75 Bn 11.22 Bn 798.00 Mn -96.43%
9 Dr Reddys Laboratories 10.11 Bn 9.94 Bn - -
10 Alkermes 8.02 Bn 7.37 Bn 397.90 Mn 91.75%

Historic Data

Download Data
DateValue
Jun 30, 2026 -139.86%
Mar 31, 2026 -186.78%
Dec 31, 2025 -96.45%
Sep 30, 2025 35.15%
Jun 30, 2025 77.21%
Mar 31, 2025 68.91%
Dec 31, 2024 -49.27%
Sep 30, 2024 -20.08%
Jun 30, 2024 48.24%
Mar 31, 2024 87.48%
Dec 31, 2023 -54.08%
Sep 30, 2023 -112.95%
Jun 30, 2023 -165.56%
Mar 31, 2023 -1,402.64%
Dec 31, 2022 45.66%
Sep 30, 2022 34.10%
Jun 30, 2022 -13.81%
Mar 31, 2022 -107.96%
Dec 31, 2021 -188.30%
Sep 30, 2021 -215.15%